# Parasitic Ulcer Treatment Trial

> **NCT06213649** · PHASE3 · RECRUITING · sponsor: **Jeremy Keenan, MD, MPH** · enrollment: 232 (estimated)

## Conditions studied

- Acanthamoeba Keratitis

## Interventions

- **DRUG:** Polyhexamethylene biguanide (PHMB)
- **DRUG:** Topical corticosteroid
- **OTHER:** Topical placebo

## Key facts

- **NCT ID:** NCT06213649
- **Lead sponsor:** Jeremy Keenan, MD, MPH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2029-07
- **Final completion:** 2029-07
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06213649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06213649, "Parasitic Ulcer Treatment Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06213649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*